ATHLETIQUE: Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary Study

Sponsor
Centre Hospitalier Universitaire de Besancon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05572424
Collaborator
(none)
40
2
19.1

Study Details

Study Description

Brief Summary

The Juvenile Idiopathic Arthritis (JIA) affects joints mobility and leads pain, impacting the practice of physical activities. Adapted Physical Activities are rehabilitation methods increasingly used, but additional studies are needed to define the nature of the physical activity for patients with JIA. The ATHLETIQUE project aims to evaluate the impact of a program integrating APA sessions together with the wearing of a pedometer watch on disease activity of patients with JIA.

Condition or Disease Intervention/Treatment Phase
  • Other: Adaptated Physical Activity (APA) + pedometer watch
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Interest of an Adapted Physical Activity (APA) Program Among Patients With Juvenile Idiopathic Arthritis: a Feasibility and Efficacy Preliminary Study
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Adaptated Physical Activity + pedometer watch

Follow an Adapted Physical Activity program during 12 weeks and wear a pedometer watch during 1 year

Other: Adaptated Physical Activity (APA) + pedometer watch
Adapted physical activities program : 12 weeks, 2 40-minutes sessions per week ( one broadcast live via online video conferencing and other one in autonomy according to a sequence of different personalized exercises defined by the APA's professional). Children are divided into 6 groups. Each session will be broken down into three parts: the warm-up (10mins), the session's corps alternating between five to eight of muscle strengthening, proprioception, and endurance exercises (20mins) and a cool-down with stretching (10mins). The physical activity performed during the sessions will be quantified with a heart rate monitor and the range of 60-70% of the maximum theoretical heart rate for each child will be respected. A pedometer watch will wear during 1 year and will provide the number of steps.

No Intervention: Control group

Usual care

Outcome Measures

Primary Outcome Measures

  1. Juvenile Arthritis Disease Activity-27 Score Assesment [Week 14]

    JADAS-27 score includes 4 components : number of inflammatory joints among 27 joints identified, a medical assesment of clinical disease activity with Visual Analogic Scale (from 0 point = worst to 10 points = best), assesment of assesment of patient's well-being by the patient or a parent with Visual Analogic Scale (froom 0 point = worst to 10 points = best), sedimentation rate (from 0 to 10).

Secondary Outcome Measures

  1. Juvenile Arthritis Disease Activity-27 Score Assesment [Weeks 26 and 50]

    JADAS-27 score includes 4 components : number of inflammatory joints among 27 joints identified, a medical assesment of clinical disease activity with Visual Analogic Scale (from 0 point = worst to 10 points = best), assesment of assesment of patient's well-being by the patient or a parent with Visual Analogic Scale (froom 0 point = worst to 10 points = best), sedimentation rate (from 0 to 10).

  2. Evaluation of the physical activity level [Weeks 13, 25 and 49]

    The difference of the medium physical activity level is assessed by the continue measures (for 7 days) of the time spent in the MVPA (Moderate to Vigorous Physical Activity) via actimetry (counts/min). Actimetric measurements will be performed before the start of the intervention to determine a value for V0, at 13 weeks (for V1), at 25 weeks (for V2), and at 49 weeks (for V3)

  3. Evaluation of the physical activity level [Each day during 50 weeks]

    The difference of the medium physical activity level is assessed by the number of steps estimated by the pedometer watch (only for the experimental group). Pedometric measurements will be performed throughout the study but collected one week per month to determine a monthly value.

  4. Quantification of the difference in muscle strength [Weeks 14, 26 and 50]

    By dynamometry (Newton)

  5. Evolution of quality of life [Weeks 14, 26 and 50]

    Difference of the score obtained in the Pediatric Quality of Life (PedsQL) tool. Score out of 100 for children assess and 100 for parents assess. A high score means a reduced quality of life.

  6. Evolution of functional capacities [Weeks 14, 26 and 50]

    Assessment by the questionnaire of the ChildHood Assessment Questionnaire (CHAQ-38) tool. Questionaire's score out of 3, it's a medium of 8 items. A high score means reduced functional capacities.

  7. Evolution of pain [Weeks 14, 26 and 50]

    Assessment by the Visual Analogic Scale (VAS) of the CHAQ-38 tool. VAS are out of 10. A high score means an increased pain.

  8. Evolution of fatigue [Weeks 14, 26 and 50]

    Difference of the score obtained in the PedsQL-Multidimensional Fatigue Scale questionnaire. Score out of 100 for children assess and 100 for parents assess. A high score means a increased fatigue.

  9. Assessment of the feasibility of the program [week 2 to 13]

    Assessment of program participation. Participation is the proportion of subjects who agree to participate in the study among eligible patients.

  10. Assessment of the feasibility of the program [week 2 to 13]

    Assessment of program completion. Completion is the proportion of subjects who complete the program and proportion of subjects who complete the exercise sessions.

  11. Assessment of the feasibility of the program [week 2 to 13]

    Assessment of program adherence. Adherence is the proportion of sessions attended by subjects.

  12. Assessment of the feasibility of the program [week 2 to 13]

    Assessment of program compliance. Compliance is the proportion of prescribed exercise during the session actually performed.

  13. Assessment of the feasibility of the program [week 1 to 50]

    Assessment of pedometer watch wearing time over the duration of the study.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Children (boys and girls) aged 6 to 17 years

  • Children with juvenile idiopathic arthritis (JIA) : oligoarticular, polyarticular, psoriatic or enthesitis-related arthritis, with more than one year of disease progression

  • Children on stable conventional or biotherapy 3 months prior to inclusion

  • Children with a computer/tablet/connected phone that allows them to follow adapted physical activities sessions online

  • If sexually active adolescents, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double barrier method, contraceptive patches)

  • Signed informed consent to participate indicating that the parent(s) understand the purpose and procedures required for the study and agree(s) that their child(ren) will participate in the study and abide by the requirements and restrictions of the study

  • Affiliation with a French social security system or beneficiary of such a system.

Non-inclusion criteria:
  • Treatment by intra-articular infiltration less than 1 month old (immobilization required after the procedure and temporary cessation of physical activity unavoidable)

  • Contraindications to physical activity

  • Subject unlikely to cooperate with the study and/or poor cooperation anticipated by the investigator

  • Subject without health insurance

  • Pregnant adolescent

  • Subject in the exclusion period of another study or is the "national volunteer register"

Exclusion criteria :
  • Intra-articular infiltration treatment during the 3 months of the adapted physical activity (APA) program (except for the temporomandibular joint)

  • Change of biotherapy during the 3 months of the APA program if the treatment is ineffective

  • Physical inability to engage in physical activity, unrelated to JIA, during the 3-month of the APA program

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Besancon

Investigators

  • Principal Investigator: Claire BALLOT-SCHMIT, MD, CHU de Besançon

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier:
NCT05572424
Other Study ID Numbers:
  • 2021/600
First Posted:
Oct 7, 2022
Last Update Posted:
Feb 3, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2023